Trial Profile
Development of an Innovative Gallium 68 Radiolabeling of DOTATOC (68Ga-DOTATOC) for PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Gallium 68-DOTATOC (Primary)
- Indications Neuroendocrine tumours
- Focus Diagnostic use
- Acronyms GALTEP
- 31 Mar 2017 Status changed from recruiting to completed.
- 09 Apr 2015 New trial record